Status:
RECRUITING
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Lead Sponsor:
University of Sao Paulo
Conditions:
Myopathy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ...
Detailed Description
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. Depending on the clinical, pathophysiological and laboratory characteristics, they may be subdivided in...
Eligibility Criteria
Inclusion
- Classification criteria - EULAR/ACR 2017
- Classification critera - Connors et al.
Exclusion
- Neoplasia
- Using heart pacemarker
- Using visceral metalic clips
- Infections (HIV, HTLV-1, Hepatitis, etc)
- Pregnance
- Previous historical of convulsions or epilepsies
Key Trial Info
Start Date :
December 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 4 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04678635
Start Date
December 12 2020
End Date
December 4 2024
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samuel K Shinjo
São Paulo, São Paulo, Brazil